| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.03 |